Skip to main content
SpringerLink
Log in

Clinical Development of Histamine H4 Receptor Antagonists

  • Chapter
  • First Online:
Histamine and Histamine Receptors in Health and Disease

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 241))

Abstract

The discovery of the histamine H4 receptor (H4R) provided a new avenue for the exploration of the physiological role of histamine, as well as providing a new drug target for the development of novel antihistamines. The first step in this process was the identification of selective antagonists to help unravel the pharmacology of the H4R relative to other histamine receptors. The discovery of the selective H4R antagonist JNJ 7777120 was vital for showing a role for the H4R in inflammation and pruritus. While this compound has been very successful as a tool for understanding the function of the receptor, it has drawbacks, including a short in vivo half-life and hypoadrenocorticism toxicity in rats and dogs, that prevented advancing it into clinical studies. Further research let to the discovery of JNJ 39758979, which, similar to JNJ 7777120, was a potent and selective H4R antagonist and showed anti-inflammatory and anti-pruritic activity preclinically. JNJ 39758979 advanced into human clinical studies and showed efficacy in reducing experimental pruritus and in patients with atopic dermatitis. However, development of this compound was terminated due to the occurrence of drug-induced agranulocytosis. This was overcome by developing another H4R antagonist with a different chemical structure, toreforant, that does not appear to have this side effect. Toreforant has been tested in clinical studies in patients with rheumatoid arthritis, asthma, or psoriasis. In conclusions there have been many H4R antagonists reported in the literature, but only a few have been studied in humans underscoring the difficulty in finding ligands with all of the properties necessary for testing in the clinic. Nevertheless, the clinical data to date suggests that H4R antagonists can be beneficial in treating atopic dermatitis and pruritus.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahmad SF, Zoheir KMA, Abdel-Hamied HE, Alrashidi I, Attia SM, Bakheet SA, Ashour AE, Abd-Allah ARA (2014) Role of a histamine 4 receptor as an anti-inflammatory target in carrageenan-induced pleurisy in mice. Immunology 142:374–383

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ahmad SF, Ansari MA, Zoheir KMA, Bakheet SA, Korashy HM, Nadeem A, Ashour AE, Attia SM (2015) Regulation of TNF-α and NF-κB activation through the JAK/STAT signaling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation. Immunobiology 220:889–898

    Article  CAS  PubMed  Google Scholar 

  • Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD (2008) Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem 51:6571–6580

    Article  CAS  PubMed  Google Scholar 

  • Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146:657–665

    Article  PubMed  Google Scholar 

  • Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC (1987) Highly potent and selective ligands for histamine H3-receptors. Nature (London, U K) 327:117–123

    Article  CAS  Google Scholar 

  • Ballerini C, Aldinucci A, Luccarini I, Galante A, Manuelli C, Blandina P, Katebe M, Chazot PL, Masini E, Passani MB (2013) Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 170:67–77

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Beermann S, Glage S, Jonigk D, Seifert R, Neumann D (2012) Opposite effects of mepyramine on JNJ 7777120-induced amelioration of experimentally induced asthma in mice in sensitization and provocation. PLoS One 7:e30285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bell JK, McQueen DS, Rees JL (2004) Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice. Br J Pharmacol 142:374–380

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Buckland KF, Williams TJ, Conroy DM (2003) Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br J Pharmacol 140:1117–1127

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coruzzi G, Adami M, Guaita E, de Esch IJP, Leurs R (2007) Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol 563:240–244

    Article  CAS  PubMed  Google Scholar 

  • Cowart MD, Altenbach RJ, Liu H, Hsieh GC, Drizin I, Milicic I, Miller TR, Witte DG, Wishart N, Fix-Stenzel SR, McPherson MJ, Adair RM, Wetter JM, Bettencourt BM, Marsh KC, Sullivan JP, Honore P, Esbenshade TA, Brioni JD (2008) Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem 51:6547–6557

    Article  CAS  PubMed  Google Scholar 

  • Cowden JM, Riley JP, Ma JY, Thurmond RL, Dunford PJ (2010a) Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines. Respir Res 11:86

    Article  PubMed  PubMed Central  Google Scholar 

  • Cowden JM, Zhang M, Dunford PJ, Thurmond RL (2010b) The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol 130:1023–1033

    Article  CAS  PubMed  Google Scholar 

  • Cowden JM, Yu F, Challapalli M, Huang J-F, Kim S, Fung-Leung W-P, Ma JY, Riley JP, Zhang M, Dunford PJ, Thurmond RL (2013) Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo. Inflamm Res 62:599–607

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cowden JM, Yu F, Banie H, Farahani M, Ling P, Nguyen S, Riley JP, Zhang M, Zhu J, Dunford PJ, Thurmond RL (2014) The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Ann Rheum Dis 73:600–608

    Article  PubMed  Google Scholar 

  • Crisp AJ (1984) Studies of histamine in the rheumatoid joint. Rheumatol Int 4:125–128

    Article  CAS  PubMed  Google Scholar 

  • del Rio R, Noubade R, Saligrama N, Wall EH, Krementsov DN, Poynter ME, Zachary JF, Thurmond RL, Teuscher C (2012) Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system. J Immunol 188:541–547

    Article  PubMed  Google Scholar 

  • Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL (2006) The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J Immunol 176:7062–7070

    Article  CAS  PubMed  Google Scholar 

  • Dunford PJ, Williams KN, Desai PJ, Karlsson L, McQueen D, Thurmond RL (2007) Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 119:176–183

    Article  CAS  PubMed  Google Scholar 

  • Durant GJ, Ganellin CR, Parsons ME (1975) Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem 18:905–909

    Article  CAS  PubMed  Google Scholar 

  • Engelhardt H, de Esch IJP, Kuhn D, Smits RA, Zuiderveld OP, Dobler J, Mayer M, Lips S, Arnhof H, Scharn D, Haaksma EEJ, Leurs R (2012) Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligands. Eur J Med Chem 54:660–668

    Article  CAS  PubMed  Google Scholar 

  • Frewin DB, Cleland LG, Jonsson JR, Robertson PW (1986) Histamine levels in human synovial fluid. J Rheumatol 13:13–14

    CAS  PubMed  Google Scholar 

  • Godfrey HP, Ilardi C, Engber W, Graziano FM (1984) Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27:852–856

    Article  CAS  PubMed  Google Scholar 

  • Gotis-Graham I, McNeil PH (1997) Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum 40:479–489

    Article  CAS  PubMed  Google Scholar 

  • Gotis-Graham I, Smith MD, Parker A, McNeil HP (1998) Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann Rheum Dis 57:664–671

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M (2001) The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 10:11–18

    Article  CAS  PubMed  Google Scholar 

  • Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung W-P (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305:1212–1221

    Article  CAS  PubMed  Google Scholar 

  • Hsieh GC, Chandran P, Salyers AK, Pai M, Zhu CZ, Wensink EJ, Witte DG, Miller TR, Mikusa JP, Baker SJ, Wetter JM, Marsh KC, Hancock AA, Cowart MD, Esbenshade TA, Brioni JD, Honore P (2010) H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav 95:41–50

    Article  CAS  PubMed  Google Scholar 

  • Ikawa Y, Suzuki M, Shiono S, Ohki E, Moriya H, Negishi E, Ueno K (2005) Histamine H4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biol Pharm Bull 28:2016–2018

    Article  CAS  PubMed  Google Scholar 

  • Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, Jiang W, Wilson SJ, Thurmond RL, Karlsson L, Edwards JP, Lovenberg TW, Carruthers NI (2003) The first potent and selective non-imidazole human histamine H4 receptor antagonists. J Med Chem 46:3957–3960

    Article  CAS  PubMed  Google Scholar 

  • Klein SC, Peterson ME (2010) Canine hypoadrenocorticism: part I. Can Vet J 51:63–69

    CAS  PubMed  PubMed Central  Google Scholar 

  • Koenig JR, Liu H, Drizin I, Witte DG, Carr TL, Manelli AM, Milicic I, Strakhova MI, Miller TR, Esbenshade TA, Brioni JD, Cowart M (2010) Rigidified 2-aminopyrimidines as histamine H4 receptor antagonists: effects of substitution about the rigidifying ring. Bioorg Med Chem Lett 20:1900–1904

    Article  CAS  PubMed  Google Scholar 

  • Kollmeier A, Francke K, Chen B, Dunford PJ, Greenspan AJ, Xia Y, Xu XL, Zhou B, Thurmond R (2014) The H4 receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects. J Pharmacol Exp Ther 350:181–187

    Article  PubMed  Google Scholar 

  • Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R (2005) Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: Identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J Pharmacol Exp Ther 314:1310–1321

    Article  CAS  PubMed  Google Scholar 

  • Liu C, Ma X-J, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol Pharmacol 59:420–426

    CAS  PubMed  Google Scholar 

  • Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LGR, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD (2008) cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem 51:7094–7098

    Article  CAS  PubMed  Google Scholar 

  • Lucarini L, Pini A, Rosa AC, Lanzi C, Durante M, Chazot PL, Krief S, Schreeb A, Stark H, Masini E (2016) Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis. Pharmacol Res 111:740–748

    Article  CAS  PubMed  Google Scholar 

  • Mahapatra S, Albrecht M, Behrens B, Dittrich A-M, Jirmo A, Behrens G, Hartwig C, Neumann D, Bahre H, Raap U, Herrick C (2014) Delineating the role of histamine-1- and −4-receptors in a mouse model of th2-dependent antigen-specific skin inflammation. PLoS One 9:e87296

    Article  PubMed  PubMed Central  Google Scholar 

  • Matsushita A, Seike M, Okawa H, Kadawaki Y, Ohtsu H (2012) Advantages of histamine H4 receptor antagonist usage with H1 receptor antagonist for the treatment of murine allergic contact dermatitis. Exp Dermatol 21:714–715

    Article  CAS  PubMed  Google Scholar 

  • Murata Y, Song M, Kikuchi H, Hisamichi K, Xu XL, Greenspan A, Kato M, Chiou C-F, Kato T, Guzzo C, Thurmond RL, Ohtsuki M, Furue M (2015) Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis. J Dermatol 42:129–139

    Article  CAS  PubMed  Google Scholar 

  • Nakano Y, Takahashi Y, Ono R, Kurata Y, Kagawa Y, Kamei C (2009) Role of histamine H4 receptor in allergic conjunctivitis in mice. Eur J Pharmacol 608:71–75

    Article  CAS  PubMed  Google Scholar 

  • Naumann R, Felber W, Heilemann H, Reuster T (1999) Olanzapine-induced agranulocytosis. Lancet 354:566–567

    Article  CAS  PubMed  Google Scholar 

  • Ohsawa Y, Hirasawa N (2012) The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy 67:1014–1022

    Article  CAS  PubMed  Google Scholar 

  • Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WLS, Stark H, Thurmond RL, Haas HL (2015) International Union of Basic and Clinical Pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 67:601–655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petit-Bertron A-F, Machavoine F, Defresne MP, Gillard M, Chatelain P, Mistry P, Schneider E, Dy M (2009) H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells. PLoS One 4

    Google Scholar 

  • Pini A, Somma T, Formicola G, Lucarini L, Bani D, Thurmond R, Masini E (2014) Effects of a selective histamine H4R antagonist on inflammation in a model of carrageenan-induced pleurisy in the rat. Curr Pharm Des 20:1338–1344

    Article  CAS  PubMed  Google Scholar 

  • Rosa AC, Pini A, Lucarini L, Lanzi C, Veglia E, Thurmond RL, Stark H, Masini E (2014) Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment. J Pharmacol Exp Ther 351:308–316

    Article  PubMed  Google Scholar 

  • Rossbach K, Wendorff S, Sander K, Stark H, Gutzmer R, Werfel T, Kietzmann M, Baeumer W (2009) Histamine H4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol 18:57–63

    Article  CAS  PubMed  Google Scholar 

  • Rossbach K, Nassenstein C, Gschwandtner M, Schnell D, Sander K, Seifert R, Stark H, Kietzmann M, Baeumer W (2011) Histamine H1, H3 and H4 receptors are involved in pruritus. Neuroscience 190:89–102

    Article  CAS  PubMed  Google Scholar 

  • Savall BM, Gomez L, Chavez F, Curtis M, Meduna SP, Kearney A, Dunford P, Cowden J, Thurmond RL, Grice C, Edwards JP (2011) Tricyclic aminopyrimidine histamine H4 receptor antagonists. Bioorg Med Chem Lett 21:6577–6581

    Article  CAS  PubMed  Google Scholar 

  • Savall BM, Chavez F, Tays K, Dunford P, Cowden J, Hack MD, Wolin R, Thurmond RL, Edwards JP (2014) Discovery and SAR of 6-Alkyl-2,4-diaminopyrimidines as H4 receptor antagonists. J Med Chem 57:2429–2439

    Article  CAS  PubMed  Google Scholar 

  • Schirmer B, Rezniczek T, Seifert R, Neumann D (2015) Proinflammatory role of the histamine H4 receptor in dextrane sodium sulfate-induced acute colitis. Biochem Pharmacol 98:102–109

    Article  CAS  PubMed  Google Scholar 

  • Schneider EH, Seifert R (2016) The histamine H4-receptor and the central and peripheral nervous system: a critical analysis of the literature. Neuropharmacology 106:116–128

    Article  CAS  PubMed  Google Scholar 

  • Seike M, Furuya K, Omura M, Hamada-Watanabe K, Matsushita A, Ohtsu H (2010) Histamine H4 receptor antagonist ameliorates chronic allergic contact dermatitis induced by repeated challenge. Allergy 65:319–326

    Article  CAS  PubMed  Google Scholar 

  • Shin N, Covington M, Bian D, Zhuo J, Bowman K, Li Y, Soloviev M, Qian D-Q, Feldman P, Leffet L, He X, Wang KH, Krug K, Bell D, Czerniak P, Hu Z, Zhao H, Zhang J, Yeleswaram S, Yao W, Newton R, Scherle P (2012) INCB38579, a novel and potent histamine H4 receptor small molecule antagonist with anti-inflammatory pain and anti-pruritic functions. Eur J Pharmacol 675:47–56

    Article  CAS  PubMed  Google Scholar 

  • Smith FM, Haskelberg H, Tracey DJ, Moalem-Taylor G (2007) Role of histamine H3 and H4 receptors in mechanical hyperalgesia following peripheral nerve injury. Neuroimmunomodulation 14:317–325

    Article  CAS  PubMed  Google Scholar 

  • Somma T, Cinci L, Formicola G, Pini A, Thurmond R, Ennis M, Bani D, Masini E (2013) A selective antagonist of histamine H4 receptors prevents antigen-induced airway inflammation and bronchoconstriction in guinea pigs: involvement of lipocortin-1. Br J Pharmacol 170:200–213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Suwa E, Yamaura K, Oda M, Namiki T, Ueno K (2011) Histamine H4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. Eur J Pharmacol 667:383–388

    Article  CAS  PubMed  Google Scholar 

  • Takahashi Y, Kagawa Y, Izawa K, Ono R, Akagi M, Kamei C (2009) Effect of histamine H4 receptor antagonist on allergic rhinitis in mice. Int Immunopharmacol 9:734–738

    Article  CAS  PubMed  Google Scholar 

  • Takeshita K, Sakai K, Bacon KB, Gantner F (2003) Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 307:1072–1078

    Article  CAS  PubMed  Google Scholar 

  • Tesfa D, Keisu M, Palmblad J (2009) Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management. Am J Hematol 84:428–434

    Article  CAS  PubMed  Google Scholar 

  • Tetlow LC, Woolley DE (1995) Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalization studies. Ann Rheum Dis 54:896–903

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tetlow LC, Woolley DE (1996) Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages. Ann Rheum Dis 55:548–551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thaci D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, Soong W, Worm M, Szepietowski JC, Sofen H, Kawashima M, Wu R, Weinstein SP, Graham NMH, Pirozzi G, Teper A, Sutherland ER, Mastey V, Stahl N, Yancopoulos GD, Ardeleanu M (2015) Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet 387:40–52

    Article  PubMed  Google Scholar 

  • Thurmond RL (2015) The histamine H4 receptor: from orphan to the clinic. Front Pharmacol 6:1–11

    Article  CAS  Google Scholar 

  • Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung W-P, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther 309:404–413

    Article  CAS  PubMed  Google Scholar 

  • Thurmond RL, Chen B, Dunford PJ, Greenspan AJ, Karlsson L, La D, Ward P, Xu XL (2014) Clinical and preclinical characterization of the histamine H4 receptor antagonist JNJ-39758979. J Pharmacol Exp Ther 349:176–184

    Article  PubMed  Google Scholar 

  • Thurmond RL, Kazerouni K, Chaplan SR, Greenspan AJ (2015) Antihistamines and itch. Handb Exp Pharmacol 226:257–290

    Article  CAS  PubMed  Google Scholar 

  • Thurmond RL, Greenspan A, Radziszewski W, Xu XL, Miao Y, Chen B, Ge T, Zhou B, Baker DG, Pavlova D, Ritchlin CT, Tanaka Y, Takeuchi T, Smolen JS (2016) Toreforant, a histamine H4 receptor antagonist, in patients with active rheumatoid arthritis despite methotrexate therapy: results of 2 phase II studies. J Rheumatol 43:1637–1642

    Article  PubMed  Google Scholar 

  • Thurmond RL, Chen B, Dunford PJ, Eckert W, Karlsson L, La D, Ward P, Xu XL, Greenspan AJ (2017) Pharmacology and clinical activity of toreforant, a histamine H4 receptor antagonist. J Ann Pharmacol Pharm (in press.)

    Google Scholar 

  • Varga C, Horvath K, Berko A, Thurmond RL, Dunford PJ, Whittle BJR (2005) Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur J Pharmacol 522:130–138

    Article  CAS  PubMed  Google Scholar 

  • Venable JD, Cai H, Chai W, Dvorak CA, Grice CA, Jablonowski JA, Shah CR, Kwok AK, Ly KS, Pio B, Wei J, Desai PJ, Jiang W, Nguyen S, Ling P, Wilson SJ, Dunford PJ, Thurmond RL, Lovenberg TW, Karlsson L, Carruthers NI, Edwards JP (2005) Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: Potent human histamine H4 antagonists. J Med Chem 48:8289–8298

    Article  CAS  PubMed  Google Scholar 

  • Wang M, Han J, Domenico J, Shin YS, Jia Y, Gelfand EW (2016) Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function. Allergy 71:1561–1574

    Google Scholar 

  • Werfel T, Lynch V, Asher A, Tsianakas A, Gupta B, Sarmiento R, Ploszczuk A, Kuna P, Majorek-Olechowska B, Cimoszko B, Nikkels A, Hofman T, Staubach P, Breuer K, Gawlik A, Buczylko K, Morren M-A, Layton G, Yeadon M, Whitlock L, Purkins L, Liu W, Osterloh I, Jimenez P (2016) A phase 2a proof of concept clinical trial to evaluate ZPL-3893787 (ZPL-389), a potent, oral histamine H4 receptor antagonist for the treatment of moderate to severe atopic dermatitis (AD) in adults. In: EAACI 2016 meeting abstract

    Google Scholar 

  • Williams HC (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352:2314–2324

    Article  CAS  PubMed  Google Scholar 

  • Yamaura K, Oda M, Suwa E, Suzuki M, Sato H, Ueno K (2009) Expression of histamine H4 receptor in human epidermal tissues and attenuation of experimental pruritus using H4 receptor antagonist. J Toxicol Sci 34:427–431

    Article  CAS  PubMed  Google Scholar 

  • Zhang M, Venable JD, Thurmond RL (2006) The histamine H4 receptor in autoimmune disease. Expert Opin Investig Drugs 15:1443–1452

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Janssen Research & Development, LLC, San Diego, CA, 92121, USA

    Robin L. Thurmond, Jennifer Venable, Brad Savall, David La, Sandra Snook, Paul J. Dunford & James P. Edwards

Authors
  1. Robin L. Thurmond
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Venable
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brad Savall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David La
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sandra Snook
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paul J. Dunford
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. James P. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robin L. Thurmond .

Editor information

Editors and Affiliations

  1. Department of Molecular and Medical Pharmacology, Graduate School of Medical and Pharmaceutical Sciences, University of Toyama, Toyama, Japan

    Yuichi Hattori

  2. Institute of Pharmacology, Medical School of Hannover, Hannover, Germany

    Roland Seifert

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Thurmond, R.L. et al. (2017). Clinical Development of Histamine H4 Receptor Antagonists. In: Hattori, Y., Seifert, R. (eds) Histamine and Histamine Receptors in Health and Disease. Handbook of Experimental Pharmacology, vol 241. Springer, Cham. https://doi.org/10.1007/164_2016_130

Download citation

Publish with us

Policies and ethics

Search

Navigation